174 related articles for article (PubMed ID: 38609979)
1. Nicotine restores olfactory function by activation of prok2R/Akt/FoxO3a axis in Parkinson's disease.
Guo Q; Wang Y; Yu L; Guan L; Ji X; Li X; Pang G; Ren Z; Ye L; Cheng H
J Transl Med; 2024 Apr; 22(1):350. PubMed ID: 38609979
[TBL] [Abstract][Full Text] [Related]
2. Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson's disease.
Yang J; Lv DJ; Li LX; Wang YL; Qi D; Chen J; Mao CJ; Wang F; Liu Y; Hu LF; Liu CF
Neurotoxicology; 2019 Jul; 73():175-182. PubMed ID: 30978411
[TBL] [Abstract][Full Text] [Related]
3. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway.
Hu M; Li F; Wang W
Drug Des Devel Ther; 2018; 12():565-573. PubMed ID: 29588573
[TBL] [Abstract][Full Text] [Related]
4. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
5. SNHG1 promotes MPP
Zhao J; Geng L; Chen Y; Wu C
Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
[TBL] [Abstract][Full Text] [Related]
6. Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.
Hang W; Fan HJ; Li YR; Xiao Q; Jia L; Song LJ; Gao Y; Jin XM; Xiao BG; Yu JZ; Ma CG; Chai Z
Metab Brain Dis; 2022 Jun; 37(5):1435-1450. PubMed ID: 35488941
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
[TBL] [Abstract][Full Text] [Related]
8. Canopy Fibroblast Growth Factor Signaling Regulator 2 (CNPY2) Inhibits Neuron Apoptosis in Parkinson's Disease via the AKT/GSK3β Pathway.
Chu M; Liu H; Xiong Z; Ju C; Zhao L; Li K; Tian S; Gu P
Curr Neurovasc Res; 2021; 18(1):102-112. PubMed ID: 34060992
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
10. Protection by rhynchophylline against MPTP/MPP
Zheng M; Chen M; Wang W; Zhou M; Liu C; Fan Y; Shi D
J Ethnopharmacol; 2021 Mar; 268():113568. PubMed ID: 33188898
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.
Piao Y; Kim HG; Oh MS; Pak YK
Biochim Biophys Acta; 2012 May; 1820(5):577-85. PubMed ID: 21856379
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TRB3 improved the MPP
Hu F; Duan M; Peng N
Neurosci Lett; 2019 Sep; 709():134352. PubMed ID: 31283965
[TBL] [Abstract][Full Text] [Related]
14. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
15. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W
J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500
[TBL] [Abstract][Full Text] [Related]
16. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
18. A Mouse Model of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Parkinson Disease Shows that 2-Aminoquinoline Targets JNK Phosphorylation.
Zhu M; Gong D
Med Sci Monit; 2020 Apr; 26():e920989. PubMed ID: 32333598
[TBL] [Abstract][Full Text] [Related]
19. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
20. Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice.
Steidinger TU; Slone SR; Ding H; Standaert DG; Yacoubian TA
PLoS One; 2013; 8(2):e56092. PubMed ID: 23409128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
